哈药集团

  • 网络Harbin Pharmaceutical Group;HPGC
哈药集团哈药集团
  1. 第四章主要分析哈药集团营销现状及其特点,对营销总体状况进行了分析,同时提出了具体的营销特点。

    Chapter four mainly analyzed the present marketing situation and characteristics of HPGC , and brought forward the specific marketing characteristics .

  2. 论文的不足之处在于对哈药集团的了解还不够深入,一些具体的操作性问题分析还不够全面。

    However , the inadequacy of this paper is that the understanding of the HPGC is not deep enough , and some analysis of specific operational problems is not comprehensive enough .

  3. 本文阐述了哈药集团制药总厂导入CIS的意义,简要分析了目前所处的市场环境。

    The thesis sets down the significance of CIS strategy to Harbin General Pharmaceutical Factory and analyses the market environment that Harbin General Pharmaceutical Factory faces in the present .

  4. 本文结合CIS战略理论,与哈药集团制药总厂的实际情况相结合,分别从理念识别、活动识别和视觉识别三大要素对哈药集团制药总厂导入CIS提出总体设想。

    Combining the theory of CIS and the circumstances of Harbin General Pharmaceutical Factory , the article lays out the collectivity introduction of CIS strategy which includes Mind Identity , Behavior Identity and Visual Identity to the factory .

  5. 哈药集团制药总厂抗生素系列产品营销策略研究

    Antibiotic Product Marketing Strategies of Harbin General Pharmaceutical Factory 's Sale Company

  6. 哈药集团发展生物制药创新机制研究哈哈米夏山口集体农庄

    The Research on Biopharmaceutical Innovation Mechanism of Harbin Pharmaceutical Group

  7. 最后根据哈药集团生物技术有限公司对搅拌釜式生物反应器的实际使用要求、生产条件、对生物反应器的基本结构进行选型。

    The article produces condition finally according to actual usage demand of medicine biotechnology Ltd of Harbin , carrying out selections on basic structure of bioreactor .

  8. 在哈药集团全面发展为国际化企业的过程中,集团的目标应该不仅在于争取较低的药品价格和高利润,还要为创建更健康社会做出应有贡献。

    In upgrading toward internationalization , Harbin Pharmaceutical Group should not only strive for low drug prices and high profit margins but healthier outcomes to the society .

  9. 为探讨工业废水处理后的污泥能否在农业上应用,以哈药集团制药总厂经生物处理产生的污泥为材料,研究水稻分蘖动态及产量形成。

    The present research intends to introduce the author 's research on the possibility to use the sewage sludge to increase rice yield by promoting the seedling tillering .

  10. 哈药集团三精制药诺捷有限责任公司-适用于胃溃疡、十二指肠溃疡、应激性溃疡、反流性食管炎和卓一艾综合症(胃泌素瘤)。

    Harbin Pharmaceutical Group three refined pharmaceutical Notier limited liability company-for gastric ulcer , duodenal ulcer , stress ulcer , reflux esophagitis and Cheuk Ai syndrome ( gastrinoma ) .

  11. 本文的目的在于帮助哈药集团制药总厂树立产品形象和企业形象,为其领导层的决策提供依据。

    The purpose of the article is to help Harbin head Pharmaceutical Factory set up image of enterprise , image of product and provide the basis to the leader 's decision-making .

  12. 因此本文选取中美两国的医药企业进行比较研究,特别是将辉瑞制药与哈药集团进行案例研究是非常有意义的。

    Therefore , this article selects pharmaceutical companies in China and the United States to form a comparative study , especially for the Pfizer Pharmaceutical Group and Harbin Pharmaceutical , which is very significant .

  13. 第五章主要分析哈药集团市场营销方面存在的问题,包括产品创新、渠道控制、定价策略、技术研发、广告内涵、品牌管理等多个领域的问题。

    The fifth part analyzed the problems of HPGC marketing , including the product innovation , channel control , pricing strategy , R & D , advertising content , brand management and other areas .